Pacific Biosciences Achieves Second Development Milestone in Clinical Diagnostics Agreement With Roche

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. ACN
7. NVDA
8. BLZE
9. IBM
10. PRIM

Go back to Pacific Biosciences Achieves Second Development Milestone in Clinical Diagnostics Agreement With Roche

Pacific Bio (PACB) Reports In-Line Q1 EPS, Achieves Second Development Milestone

May 5, 2015 5:17 PM EDT

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.27), in-line with the analyst estimate of ($0.27).

Pacific Biosciences of California, Inc. (Nasdaq: PACB), provider of the PacBio® RS II Sequencing System, today announced that it has achieved a second development milestone... More